ACTEMRA Medication Guide - Genentech
and the Southwest) where there is an increased chance for getting certain kinds of fungal infections (histoplasmosis, coccidiomycosis, or blastomycosis). These infections may happen or become more severe if you use ACTEMRA. Ask your healthcare provider, if you do not know if you have lived in an area where these infections are common.
Download ACTEMRA Medication Guide - Genentech
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.gene.com1 . HIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for
Initial dose of 4 mg/kg over 90 minute IV infusion, …
www.gene.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Herceptin safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION The …
www.gene.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RITUXAN safely and effectively. See full prescribing information for
Reference ID: 4212951 - Genentech
www.gene.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information …
Valcyte Master USPI - Genentech
www.gene.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VALCYTE ® safely and effectively. See full prescribing information …
Information, Prescribing, Prescribing information, Genentech, Valcyte
HIGHLIGHTS OF PRESCRIBING INFORMATION - Genentech
www.gene.com2 FULL PRESCRIBING INFORMATION WARNING: CARDIOMYOPATHY, INFUSION REACTIONS, EMBRYO-FETAL TOXICITY, and PULMONARY TOXICITY Cardiomyopathy Herceptin administration can …
Information, Prescribing, Prescribing information, Infusion, Genentech
HIGHLIGHTS OF PRESCRIBING INFORMATION The dose for …
www.gene.comfull prescribing information warning: fatal infusion reactions, severe mucocutaneous reactions, hepatitis b virus reactivation and progressive
OCREVUS Prescribing Information - Genentech
www.gene.comHepatitis B Virus Screening Prior to initiating OCREVUS, perform Hepatitis B virus (HBV) screening. OCREVUS is contraindicated in patients with active HBV confirmed by positive results for HBsAg and anti-HBVtests. For patients who are negative for surface antigen [HBsAg] and positive for HB core antibody [HBcAb+] or are carriers of HBV
Information, Patients, Virus, Prescribing, Prescribing information, Hepatitis, Genentech, Hepatitis b virus
HIGHLIGHTS OF PRESCRIBING INFORMATION ACTEMRA …
www.gene.com162 mg administered subcutaneously every other week, followed by an increase to every week based on clinical response Patients at or above 100 kg weight 162 mg administered subcutaneously every week Giant Cell Arteritis (2.2) Recommended Adult Subcutaneous Dosage: The recommended dose of ACTEMRA for adult patients with GCA is 162 mg
XOLAIR Prescribing Information - Genentech
www.gene.comCorticosteroid Reduction: Do not abruptly discontinue corticosteroids upon initiation of XOLAIR therapy. (5.4) Eosinophilic Conditions: Be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or Fever, Arthralgia, and Rash: Stop XOLAIR if patients develop signs and sickness. (5.6)
Information, Prescribing, Prescribing information, Corticosteroid, Genentech
Related documents
Prophylaxis and Treatment of Invasive Fungal Infections …
nssg.oxford-haematology.org.uk• If radiological features are suggestiveof invasive fungal disease consider: o B-D-glucan on serum o Early bronchoscopy with BAL and commence empirical antifungal therapy. Samples should be sent for microscopy and culture, respiratory virus PCR, fungal microscopy and culture, PCP PCR, aspergillus antigen and fungi.
Treatment, Invasive, Infections, Fungal, Prophylaxis, Prophylaxis and treatment of invasive fungal infections
Candida auris - Centers for Disease Control and Prevention
www.cdc.govprovider if you believe you have a fungal or healthcare-associated infection. Most people who get serious . Candida . infections are already sick from other medical conditions. Stopping the spread of . Candida auris. CDC is working with public health partners, healthcare workers, and laboratories to stop the spread of.
Center, Control, Centers for disease control and prevention, Disease, Prevention, Fungal, Iaru, Candida, Candida auris
The Malheur National Forest - USDA
www.fs.usda.govThe other fungal structures that may be seen are latex paint-like mats of mycelial felts that grow under the bark of live-infected trees (Fig. 6). These may be found for several years on infected trees after they have died (Fig. 7). Mycelial felts contribute to killing the host and will
Candidemia (Blood Infection) and Other Candida Infections
www.thoracic.orgCandida is the single most important cause of fungal infections worldwide. In the U.S., Candida is the 4th most common cause of bloodstream infection that can develop while you are in a hospital (also called “nosocomial” infection or hospital acquired infection). There are 17 different species of Candida. Of these,
Treatment of Fungal Infections in Adult Pulmonary Critical ...
www.thoracic.orgfungal infections have dramatically increased in recent years in response to a number of factors. Growing numbers of immune-compromised patients with malignancy, hematologic disease, and HIV, as well as those receiving immunosupressive drug regimens for the management of organ transplantation or